Media Highlights

Featured Stories

VenatoRx Pharmaceuticals Raises $42 Million Series B


Repare Therapeutics Raises $US68 Million Series A

Repare Therapeutics Raises US$68 Million Series A

CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation

CRISPR appoints Jon Terrett

Versant Ventures Launches Jecure Therapeutics


Tarveda Therapeutics Raises $30 Million in Series D Financing to Advance Pentarin Miniaturized Drug Conjugates


Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing


Versant Ventures Strengthens Global Team to Launch New $400M Fund


Versant Ventures Closes Sixth Healthcare Fund


Versant Ventures Announces Milestone with Recent Northern Biologics and BlueRock Therapeutics Deals


Northern Biologics, Mosaic Biomedicals Execute Transformative Deal


Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing


Versant Ventures Portfolio Company Turnstone Biologics completes CAD$55.3 million Series B


Nouscom Appoints New Chief Operating Officer and Strengthens the Board of Directors


Nouscom Closes Series A Financing

Nouscom Closes Series A Financing

Versant Ventures Strengthens Global Team

Versant Strengthens Global Team

Versant Ventures Backs Aprea AB Continuing Global Investment Strategy


Here To Stay: Inception Sciences Shows Why Build-To-Buy Works

Here to stay- Inception Sciences Shows Why Build-to-Buy Works

Versant Ventures Leads Series A in Turnstone Biologics Continuing Global Strategy to Access Innovation

Versant_Turnstone Press Release Oct 28

Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies

Gritstone Oncology Series A Financing News Release 10-20-15

Medtronic to Acquire Privately Held Twelve Inc.

Twelve Read More

Versant bites at the apple

Versant bites at the apple

Versant Ventures Broadens Geographic Footprint with Highline Therapeutics

Highline & New York Aug 24 Read More

Highline Therapeutics Announces Alliance with Weill Cornell Medical College to Accelerate Biotech Company Formation

Highline-Cornell Aug 24 Read More

Astellas and Anokion to Collaborate on Immune Tolerance Therapeutics

Astellas-Kanyos Bio Press Release Anokion Read More

Celgene to Acquire Quanticel Pharmaceuticals

Download PDF

Versant Ventures Closes $305 Million Healthcare Fund – US Release

Download PDF

Versant Ventures Closes $305 Million Healthcare Fund – Canadian Release

Download PDF

Versant Ventures strengthens biotechnology investment team in North America and Europe

Download PDF

Northern Biologics to Develop Antibody Therapeutics in Toronto

Download PDF

CRISPR Therapeutics Founding Scientist, Emmanuelle Charpentier Awarded 2015 Breakthrough Prize in Life Sciences

Download PDF

A new kind of biotech startup incubator comes to Montréal

Download PDF

Investors pumping cash into Minnesota life-science start-ups

Download PDF

Alcon to acquire WaveTec Vision

Download PDF

Ocular Therapeutix Shares See Small Rise in Debut

Download PDF

Irish company to buy Cadence Pharmaceuticals of San Diego

Download PDF

William Link Honored with 2014 Catalyst Award

Read More

Versant Ventures sets up Vancouver office and invests $10 million drug development

Download PDF

Versant-Backed Inception Sciences Creates Eye-Drug Startup with Bayer Healthcare

Download PDF

Sam Colella Receives Lifetime Achievement Award

Read More

Second Sight Receives First Retinal Implant FDA Approval

Download PDF

Versant, Roche Launch New-model Biotech Startup

Download PDF

News Articles